• Recent
  • Class
  • Inventors
  • Assignees
  • Top Lists
  • Pricing
  • Account
Patents-Review.com
  1. Home
  2. Inventor
  3. L
  4. Liu…
  5. Liu Yang
🔗 Permalink
Inventor profile of:

Yang Liu

City:

Vancouver

Country:

Canada

Published Applications:

5

Last publication date:

2025-10-02

Recent patent applications by Liu Yang

Yang Liu from Vancouver, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-10-02
US20250308632A1
Physics

PROGNOSIS AND TREATMENT OF MOLECULAR SUBTYPES OF PROSTATE CANCER

#2 | 2024-09-26
US20240319192A1
Physics

USE OF IMMUNE CONTENT SCORES DIAGNOSTICALLY TO PREDICT RESPONSIVENESS OF PROSTATE CANCER PATIENTS TO IMMUNOTHERAPY

#3 | 2024-01-04
US20240002944A1
Chemistry; metallurgy

METHODS AND GENOMIC CLASSIFIERS FOR IDENTIFYING HOMOLOGOUS RECOMBINATION DEFICIENCY PROSTATE CANCER

#4 | 2023-04-13
US20230115828A1
Chemistry; metallurgy

GENOMIC CLASSIFIERS FOR PROGNOSING AND TREATING CLINICALLY AGGRESSIVE LUMINAL BLADDER CANCER

#5 | 2022-07-07
US20220213557A1
Chemistry; metallurgy

NON-CODING RNA FOR SUBTYPING OF BLADDER CANCER

InventorID:

5457153 ⎘

  1. Home
  2. Inventor
  3. L
  4. Liu…
  5. Liu Yang

Some parts © 2022-2026 Patents-Review.com

Browse & Discovery
  • Home
  • Patent Classification
  • Inventor Index
  • Assignee Index
  • Interesting Applications
Search & Tools
  • Basic Search
  • Advanced Search
  • Patent Alerts
  • Top Lists
  • Statistics
Information & Resources
  • About US Patent System
  • Terms & Privacy
  • Pricing
  • Contact
Quick Access
  • Latest Applications
  • Top Inventors 2026
  • Top Assignees 2026
  • Featured Patents
Disclaimer: This website is intended for informational purposes only, and its content is based on public patent records. Please note that some sections of this website have been created or processed using machine learning models. We provide content in good faith but make no guarantees regarding accuracy or completeness. By using this site, you accept any risks and waive claims against us for errors or omissions.